Can MS be prevented?
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
There is no way to prevent MS reliably, and anyone claiming otherwise is selling something. Susceptibility is partly genetic and not modifiable.
What the epidemiology does show is that a handful of environmental factors carry most of the modifiable risk, and that the window where they matter is earlier than most people expect: adolescence and early adulthood rather than middle age.
Related pages: Multiple sclerosis (MS)
The bottom line
- MS risk comes from genetic susceptibility combined with environmental exposures.
- Prior Epstein-Barr virus infection is the strongest single environmental association.
- Smoking, low vitamin D and adolescent obesity are each associated with higher risk.
- No intervention has been shown in a trial to prevent MS.
- Whether correcting any of these factors actually prevents MS, which has never been tested in a prevention trial.
- Whether a future EBV vaccine would reduce MS incidence.
The story, step by step
- 1. Genes and environment ()
- 2. Epstein-Barr virus ()
- 3. Smoking ()
- 4. Vitamin D and sunlight ()
- 5. Weight in youth ()
What the evidence labels mean
How the risk is divided
What happens
Both matter, and only one of them can be changed.
What the research shows
- Over 200 genetic variants are associated with MS, led by HLA-DRB1*15:01. Each contributes a small amount and none causes MS on its own.
- Estimates that genetics account for around 30 percent of susceptibility and environment for the remaining 70 percent are widely quoted. They are a useful rough picture rather than a precise measurement, and heritability estimates vary considerably by method and population.
- The two interact. Several environmental factors raise risk far more in people carrying the main risk gene than in those who do not, which is why combined figures look dramatic.
- Lifetime risk in the general population is low, around 1 in 300 to 1 in 1,000 depending on the country.
- For a child or sibling of someone with MS, the risk rises to roughly 2 to 4 percent. That is several times higher and still means the large majority never develop MS.
Why it matters
Family risk is higher but remains low in absolute terms. This is the number most relatives want and rarely get given.
What's still uncertain
- Attributing fixed percentages to genes versus environment oversimplifies how they interact.
Read more
- OwieClear: HLA-DRB1*15:01 and MSOwieClear
- NINDS: Multiple SclerosisGovernment
Next: Epstein-Barr virus
The strongest association
What happens
Almost everyone with MS has had EBV, and the evidence for a causal link has strengthened considerably.
What the research shows
- EBV is the virus that causes glandular fever, also called infectious mononucleosis. Most people acquire it at some point, often in childhood with no symptoms.
- A large study of US military personnel, following people over years with stored blood samples, found that MS risk rose roughly 32-fold after EBV infection, and that infection essentially always came first.
- Having had symptomatic glandular fever, which typically means infection in adolescence or adulthood rather than early childhood, is associated with a further increase in risk.
- EBV is close to a necessary condition rather than a sufficient one: almost everyone has it and almost nobody gets MS.
- There is no way to avoid EBV reliably, and no vaccine is available. Several candidates are in clinical trials, and whether vaccination would reduce MS incidence is unknown.
Why it matters
Avoiding shared drinks and utensils around someone with active glandular fever is sensible, but it is not an MS prevention strategy and should not be presented as one.
What's still uncertain
- How EBV triggers MS is not established, and most people with EBV never develop it.
Read more
- OwieClear: Does the mono virus cause MS?OwieClear
- CDC: About infectious mononucleosisGovernment
Next: Smoking
The one that is fully avoidable
What happens
The clearest modifiable risk factor, both before and after diagnosis.
What the research shows
- Smoking is associated with roughly a 50 percent higher risk of developing MS.
- The risk is much greater in people carrying the main HLA risk variant. Figures of around a 14-fold increase refer to that combination compared with non-smokers without the risk genes, not to smoking alone.
- Passive smoke exposure, including in childhood, is also associated with increased risk.
- The proposed mechanism is chronic lung inflammation activating immune cells and increasing the permeability of the blood-brain barrier.
- Risk falls after stopping, over years rather than immediately, and smoking also worsens the course of MS once it has developed.
Why it matters
This is the one item on the list that is entirely within a person's control and matters both before and after diagnosis.
What's still uncertain
- Observational data cannot fully separate smoking from the other exposures that accompany it.
Read more
- NINDS: Multiple SclerosisGovernment
- OwieClear: Brain health and MSOwieClear
Next: Vitamin D and sunlight
Strong association, untested intervention
What happens
The latitude effect is real; what to do about it is less certain than it is usually presented.
What the research shows
- MS becomes more common with distance from the equator, and this pattern has been recognized for decades.
- Low vitamin D levels, and low sun exposure in childhood and adolescence, are associated with higher MS risk. Genetic studies using variants that affect vitamin D levels support a causal role.
- Vitamin D influences regulatory immune cells, which is a plausible mechanism.
- No trial has shown that vitamin D supplementation prevents MS, and in established MS it has not been shown to change the course.
- A note of caution: target levels promoted online, often in the range of 40 to 60 ng/mL, are above the level official bodies define as sufficient, which is around 20 ng/mL or 50 nmol/L. Very high intakes cause high blood calcium, kidney stones and kidney damage. Any supplementation above routine doses should be clinician-guided with levels checked.
- Correcting a deficiency is reasonable. Taking large doses on the assumption of prevention is not supported and is not harmless.
Why it matters
Keeping vitamin D in the normal range is sensible. Chasing high levels is where this advice turns into a risk of its own.
What's still uncertain
- Whether supplementation prevents MS remains untested in any adequately sized trial.
Read more
- NIH Office of Dietary Supplements: Vitamin DGovernment
- NINDS: Multiple SclerosisGovernment
Next: Weight in youth
A window that closes
What happens
Obesity in adolescence is associated with roughly doubled MS risk, and the timing matters.
What the research shows
- The association is with obesity during childhood, adolescence and early adulthood, not with weight later in life.
- Proposed mechanisms include chronic low-grade inflammation from fat tissue and reduced availability of vitamin D, which is stored in fat.
- The effect appears larger in people carrying the HLA risk variants, which is the same gene-environment pattern seen with smoking.
- This points at the same window as the other factors: much of modifiable MS risk is set before the age at which MS is usually diagnosed.
- The practical implication is for families rather than for individuals already diagnosed: in a family with MS, supporting healthy weight, a smoke-free home and adequate vitamin D in teenagers is the most evidence-aligned thing available.
- None of this guarantees anything, and MS is not caused by a person's choices. Framing it that way is both wrong and unkind.
Why it matters
For relatives who ask what they can do, this is the honest answer: three reasonable measures, a modest expected effect, and no guarantee.
What's still uncertain
- No prevention trial has tested whether any of these measures actually lowers MS incidence.
Read more
- NINDS: Multiple SclerosisGovernment
- National Multiple Sclerosis SocietyNonprofit